Radiotherapy-induced cardiotoxicity after the treatment of pulmonary and mediastinal solid tumors

Yükleniyor...
Küçük Resim

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Istanbul Tip Fakultesi

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Thoracic tumors are extremely common and radiotherapy plays an important role in the treatment of these malignancies. Cardiac radiation exposure which is inevitable during thoracic radiotherapy may damage the heart muscle, valves, or coronary arteries. If a malignant thoracic disease can be successfully treated with the contribution of radiotherapy, long-term cardiac toxicity will become a critical factor in determining survival. Therefore, radiation oncologists have recently focused on efforts to provide local disease control without causing toxicity. Over time, advances in radiotherapy techniques have made it possible to significantly limit the dose of cardiac structures while effectively treating the thoracic tumor. Intensity-modulated radiotherapy techniques are beneficial in reducing the cardiac dose and therefore cardiac toxicity. Advanced particle radiotherapy applications such as proton therapy have the potential to improve tumor cell killing efficiency and reduce the risk of cardiac complications. Close and long-term cooperation between radiation oncologists and cardiologists is important in the follow-up of patients undergoing thoracic radiotherapy. © 2022, Turkish Society for Radiation Oncology.

Açıklama

Anahtar Kelimeler

Cardiotoxicity, Lung Cancer, Thoracic Radiotherapy, Thoracic Sarcomas, Thymic Tumors

Kaynak

Turk Onkoloji Dergisi

WoS Q Değeri

N/A

Scopus Q Değeri

Q4

Cilt

37

Sayı

2

Künye

Saynak, M., Türkkan, G., Nurlu, D., & Özgüven, Y. (2022). Radiotherapy-induced cardiotoxicity after the treatment of pulmonary and mediastinal solid tumors. Turk Onkoloji Dergisi, 37(2), 20-27. doi:10.5505/tjo.2022.S1004